Phillip Morris International (PM) urges FDA advisory committee to recommend authorising Zyn as modified-risk tobacco

Philip Morris International urging the FDA to classify Zyn as a modified-risk tobacco product could open the door for wider acceptance and sales growth in a well-defined market segment.

Newsquawk StaffPublished On the live feed at 3 more headlines followed before this page went public
Newsquawk headlinesUTC

EU is to suspend retailatroy tariffs on EUR 93bln of US goods for a six month period, Bloomberg reports citing spokesperson Gill

Lloyds (LLOY LN) is reportedly no longer in the running for Evelyn partners, according to reports

Phillip Morris International (PM) urges FDA advisory committee to recommend authorising Zyn as modified-risk tobacco

The US warns senior Iraqi politicians, threatening state sanctions against Iraq if an Iran backed armed group joins the next government, according to sources

China and Russia have vowed to strengthen APAC coordination

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This move emphasizes PM's strategic pivot towards reduced-risk products, which may positively influence investor sentiment and impact the overall tobacco sector as regulatory landscapes evolve.

Related headlines

The whole workspace, free to try.

Try it free